ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma
In: Reyes F, Lepage E, Ganem G, Mola TJ, Bre P, Cofr B, Morel P, Ferme C, Bosly A, Lederl P, Laurent G, Tly H; Groupe d'Etude des Lymphomes de l'Adulte (GELA). ACVBP versus CHOP plus radtherapy for localed aggresse lymphoma. N Engl J Med. 2005 Mar 24;352(12):1197-205. do 10.1056/NEJMoa042040. Mler TP, Dahlberg S, Cassady JR, Adelste DJ, Spr CM, Grogan TM, LeBlanc M, Carl S, Chase E, Fher R Chemotherapy alone compared wh chemotherapy plus radtherapy for localed termedte- and hh-grade non-Hodgk's lymphoma. N Engl J Med. 1998 Jul 2;339(1):21-6. do 10.1056/NEJM199807023390104. Feugr P, Van Hoof A, Sebban C, Solal-Celny P, Bouabdallah R, Ferme C, Chrtn B, Lepage E, Tly H, Morschhauser F, Gaulard P, Salles G, Bosly A, Gselbrecht C, Reyes F, Cofr B. Long-term results of the R-CHOP study the treatment of elderly patnts wh dfuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Cl Oncol. 2005 Jun 20;23(18):4117-26. do 10.1200/JCO.2005.09.131. Epub 2005 May 2. Tly H, Lepage E, Cofr B, Blanc M, Herbrecht R, Bosly A, Attal M, Flet G, Guettr C, Mola TJ, Gselbrecht C, Reyes F; Groupe d'Etude des Lymphomes de l'Adulte. tense conventnal chemotherapy (ACVBP regen) compared wh standard CHOP for poor-prognos aggresse non-Hodgk lymphoma. Blood. 2003 Dec 15;102(13):4284-9. do 10.1182/blood-2003-02-0542. Epub 2003 Aug 14. Randomized Study of ACVBP Versus ACVBP Plus Rituximab in Previously Untreated Patients Aged From 18 to 65 Years With Low-risk Localized Diffuse Large B-cell Lymphoma (Age-adjusted IPI = 0)
Online
report
| Titel: |
ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma
|
|---|---|
| Autor/in / Beteiligte Person: | Amgen |
| Link: | |
| Quelle: | Reyes F, Lepage E, Ganem G, Mola TJ, Bre P, Cofr B, Morel P, Ferme C, Bosly A, Lederl P, Laurent G, Tly H; Groupe d'Etude des Lymphomes de l'Adulte (GELA). ACVBP versus CHOP plus radtherapy for localed aggresse lymphoma. N Engl J Med. 2005 Mar 24;352(12):1197-205. do 10.1056/NEJMoa042040. Mler TP, Dahlberg S, Cassady JR, Adelste DJ, Spr CM, Grogan TM, LeBlanc M, Carl S, Chase E, Fher R Chemotherapy alone compared wh chemotherapy plus radtherapy for localed termedte- and hh-grade non-Hodgk's lymphoma. N Engl J Med. 1998 Jul 2;339(1):21-6. do 10.1056/NEJM199807023390104. Feugr P, Van Hoof A, Sebban C, Solal-Celny P, Bouabdallah R, Ferme C, Chrtn B, Lepage E, Tly H, Morschhauser F, Gaulard P, Salles G, Bosly A, Gselbrecht C, Reyes F, Cofr B. Long-term results of the R-CHOP study the treatment of elderly patnts wh dfuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Cl Oncol. 2005 Jun 20;23(18):4117-26. do 10.1200/JCO.2005.09.131. Epub 2005 May 2. Tly H, Lepage E, Cofr B, Blanc M, Herbrecht R, Bosly A, Attal M, Flet G, Guettr C, Mola TJ, Gselbrecht C, Reyes F; Groupe d'Etude des Lymphomes de l'Adulte. tense conventnal chemotherapy (ACVBP regen) compared wh standard CHOP for poor-prognos aggresse non-Hodgk lymphoma. Blood. 2003 Dec 15;102(13):4284-9. do 10.1182/blood-2003-02-0542. Epub 2003 Aug 14. Randomized Study of ACVBP Versus ACVBP Plus Rituximab in Previously Untreated Patients Aged From 18 to 65 Years With Low-risk Localized Diffuse Large B-cell Lymphoma (Age-adjusted IPI = 0) |
| Medientyp: | report |
| Sonstiges: |
|